YucaiWangMD

PubMed

• 1 citations
  Characteristics and outcomes of incidentally diagnosed diffuse large B-cell lymphoma and implications for cancer screening.
  Suheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, Robyn L Kuchler, Grzegorz S Nowakowski
  American Journal of Hematology. 2025-01-01
• Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance.
  Allison M Bock, Kerstin Wenzl, Joseph P Novak, Matthew E Stokes, Melissa A Hopper
  Hematological Oncology. 2025-01-01
• Challenges of treating mantle cell lymphoma in older adults.
  Javier Muñoz, Mazie Tsang, Yucai Wang, Tycel Phillips
  Leukemia & Lymphoma. 2024-12-11

Abstracts/Posters

• BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression
  Yucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
  Yucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Outcomes of stem cell transplant in patients with Richter transformation. 
  2019 ASCO Annual Meeting - 6/1/2019
• Efficacy of frontline treatment regimens in follicular lymphoma: A network meta-analysis of phase III randomized controlled trials. 
  2019 ASCO Annual Meeting - 6/1/2019
• Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Distinct immune signatures in chronic lymphocytic leukemia (CLL) and Richteras syndrome (RS). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
• Join now to see all